Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Background Episodes of depression are the most frequent cause of disability among patients with bipolar disorder. The effectiveness and safety of standard antidepressant agents for depressive episodes associated with bipolar disorder (bipolar depression) have not been well studied. Our study was designed to determine whether adjunctive antidepressant therapy reduces symptoms of bipolar depression without increasing the risk of mania. Methods In this double-blind, placebo-controlled study, we randomly assigned subjects with bipolar depression to receive up to 26 weeks of treatment with a mood stabilizer plus adjunctive antidepressant therapy or a mood stabilizer plus a matching placebo, under conditions generalizable to routine clinical care. A standardized clinical monitoring form adapted from the mood-disorder modules of the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, fourth edition, was used at all follow-up visits. The primary outcome was the percentage of subjects in each treatment group meeting the criterion for a durable recovery (8 consecutive weeks of euthymia). Secondary effectiveness outcomes and rates of treatment-emergent affective switch (a switch to mania or hypomania early in the course of treatment) were also examined. Results Forty-two of the 179 subjects (23.5%) receiving a mood stabilizer plus adjunctive antidepressant therapy had a durable recovery, as did 51 of the 187 subjects (27.3%) receiving a mood stab…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Based on negative placebo‐controlled data, we do not recommend paroxetine (level 2 negative).245”
In the citing paper
“Antimanic medications reduce depressive symptoms in only one-third of patients (2).”
From Adjunctive Bright Light Therapy for Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Trial (2018) · cites this paper as [2]
Citations
Cites
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
The mini international neuropsychiatric interview
Lecrubier, Y., Sheehan, D., Hergueta, T., & Weiller, E. (1998) · European Psychiatry · doi:10.1016/s0924-9338(99)80239-9 · Cited by 5,872
The Structured Clinical Interview for DSM-III-R (SCID): I: History, Rationale, and Description
Spitzer, R. L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820080032005 · Cited by 4,336
The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder
Judd, L. L., Akiskal, H. S., Schettler, P. J., Endicott, J., Maser, J., Solomon, D. A., Leon, A. C., Rice, J. A., & Keller, M. B. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.530 · Cited by 2,106
Prevalence and Treatment of Mental Disorders, 1990 to 2003
Kessler, R. C., Demler, O., Frank, R. G., Olfson, M., Pincus, H. A., Walters, E. E., Wang, P., Wells, K. B., & Zaslavsky, A. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmsa043266 · Cited by 1,910
Extending Indications for Long-Term Pharmacotherapy: Opportunities and Challenges
Kane, J. M. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.1.1 · Cited by 987
Tohen, M., Vieta, E., Calabrese, J., Ketter, T. A., Sachs, G., Bowden, C., Mitchell, P. B., Centorrino, F., Risser, R., Baker, R. W., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.11.1079 · Cited by 908
Self-citationPerlis, R. H., Ostacher, M. J., Patel, J. K., Marangell, L. B., Zhang, H., Wisniewski, S. R., Ketter, T. A., Miklowitz, D. J., Otto, M. W., Gyulai, L., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.217 · Cited by 689
Self-citationPrevalence and Treatment of Mental Disorders
(2005) · New England Journal of Medicine · doi:10.1056/nejmc051936 · Cited by 650
Research works printed but not linked: 4
- Murray CJ, 1994, Bull World Health Organ, 72, 495
- Sheehan DV, 1998, J Clin Psychiatry, 59, 22
- Sachs GS, 1994, J Clin Psychiatry, 55, 391
- 10.1037/0021-843X.108.4.579 · doi:10.1037/0021-843x.108.4.579 · Paper page
Cited by
Items 401–500 of 935
An update on the treatment of bipolar depression
Azorin, J., & Kaladjian, A. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560802653172 · Cited by 15
“[51] , which was part of the Systematic Treatment Enhancement Programme for Bipolar Disorder (the STEP-BD), the fact that the vast majority of patients were likely to have displayed non-response to antidepressants before randomization, and had a high rate of co-morbid conditions, might have contributed to the negative…”
BackgroundResultTreatment of acute bipolar depression
Shen, Y. (2018) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_71_18 · Cited by 20
“Three hundred and thirty-six patients were randomized to receive treatment with mood stabilizer and adjuvant antidepressant therapy (bupropion or paroxetine) (n = 179) or placebo (n = 187) [36].”
MethodSamuels, A., Baum, M. L., Luchsinger, J. R., Mealer, R. G., & Ross, R. (2021) · Cambridge University Press eBooks · doi:10.1017/9780511846403.002 · Cited by 15
What is the best treatment for bipolar depression?
Young, L. T. (2008) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0845 · Cited by 17
“However, the recently published results from the STEP-BD project found no benefit to adding an antidepressant (paroxetine or bupropion; n = 179) compared with placebo (n = 187) to a mood stabilizer in a large naturalistic sample of patients with bipolar I and II disorders.(2) This intriguing finding certainly question…”
The impact of body mass index on the clinical features of bipolar disorder: A STEP‐BD study
Kadriu, B., Deng, Z., Kraus, C., Johnston, J. N., Fijtman, A., Henter, I. D., Kasper, S. F., & Zarate, C. A. (2023) · Bipolar Disorders · doi:10.1111/bdi.13370 · Cited by 19
“33 Once enrolled, participants could receive care for as long as they were in the program— up to 5 years— and were monitored systematically, even when they were feeling well.”
BackgroundGenetic approaches to a better understanding of bipolar disorder
Offord, J. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.10.001 · Cited by 17
Bipolar Disorder is Common in Depressed Primary Care Patients
Dubovsky, S. L., Leonard, K. E., Griswold, K. S., Daurignac, E. C., Hewitt, B., Fox, C. H., Seymour, D. J., Dubovsky, A. N., & deGruy, F. V. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.09.2468 · Cited by 14
The Bipolar Spectrum in Migraine, Cluster and Chronic Tension Headache
Robbins, L. D. (2008) · European Neurological Review · doi:10.17925/enr.2008.03.01.123 · Cited by 14
Fornaro, M., Kardash, L., Novello, S., Fusco, A., Anastasia, A., Berardis, D. D., Perna, G., & Carta, M. G. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1428554 · Cited by 16
“or maximum-dose strategies attempt to increase the efficacy of established drug targets [3,4].”
BackgroundManagement of bipolar I depression: clinical utility of lurasidone
El‐Mallakh, R. S., Findlay, L., & El-Mallakh, P. L. (2015) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s57695 · Cited by 14
“16 22 Furthermore, while much research has focused on the problem of induction of a manic state due to the use of antidepressants, research suggests that antidepressants can induce at least three distinct problems in bipolar patients.”
The management of bipolar disorder
Saunders, K., & Geddes, J. R. (2016) · British Journal of Hospital Medicine · doi:10.12968/hmed.2016.77.3.175 · Cited by 16
Faedda, G. L., & Marangoni, C. (2016) · CNS Spectrums · doi:10.1017/s1092852916000493 · Cited by 15
Berk, M., Ng, F., Dodd, S., Goldberg, J. F., & Malhi, G. S. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02098.x · Cited by 15
“, in their placebo-controlled trial of adjunctive antidepressant therapy for bipolar depression, defined switching as the emergence of hypomania or mania meeting the DSM-IV criteria or requiring clinical intervention.(8) Although these clinical trials have set different operationalized criteria for switching, at the c…”
BackgroundAntidepressants are not all created equal
Parikh, S. V. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60047-7 · Cited by 14
US Psychiatric Residents’ Treatment of Patients With Bipolar Disorder
Rakofsky, J. J., & Dunlop, B. W. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31824857ad · Cited by 14
“This is noteworthy given the risk of manic induction(28) and recently reported data suggesting that SSRIs are not effective in the treatment of bipolar depression.(29) Notably, SSRIs were also one of the classes of medication discontinued most often.”
ResultLieberman, D. Z., Kolodner, G., Massey, S. H., & Williams, K. P. (2009) · Journal of Addictive Diseases · doi:10.1080/10550880903182994 · Cited by 14
“3 , 4 Safety concerns include the risk of cycle acceleration, in which periods of euthymic mood are shortened following antidepressant use, 5 and affective “switching,” in which patients with depression develop a manic, hypomanic, or mixed episode.”
BackgroundHypomanic switch during vortioxetine treatment: a case report
Aydın, E. P., Dalkıran, M., Özer, Ö. A., & Karamustafalıoğlu, O. (2018) · Psychiatry and Clinical Psychopharmacology · doi:10.1080/24750573.2018.1435602 · Cited by 13
George, S., Maiti, R., Mishra, A., Mishra, B. R., & Jena, M. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221078758 · Cited by 14
“However, the evidence from clinical trials in bipolar depression is very limited and the effect of antidepressants in the treatment of bipolar depression remains controversial (Ghaemi et al., 2003; Sachs et al., 2007).”
BackgroundDivalproex extended-release in acute bipolar II depression
Wang, P. W., Nowakowska, C., Chandler, R. A., Hill, S. J., Nam, J. Y., Culver, J. L., Keller, K. L., & Ketter, T. A. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.10.021 · Cited by 13
“In a randomized study of up to 26 weeks duration, patients with Bipolar Disorder receiving a mood stabilizer without an antidepressant had rates of durable recovery at least as good as Bipolar similar patients receiving both mood stabilizer together with an antidepressant (Sachs et al., 2007).”
BackgroundSelf-citationBupropion-Induced Mania and Hypomania: A Report of Two Cases
Aggarwal, A., & Sharma, R. (2011) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.23.2.e51 · Cited by 15
Bipolar depression: trial-based insights to guide patient care
Kemp, D. E., Muzina, D. J., Mclntyre, R. S., & Calabrese, J. R. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.2/dekemp · Cited by 15
“These results, however, are at odds with recent findings from the STEP-BD program which evaluated the efficacy, safety, and tolerability of adjunctive antidepressants in bipolar disorder.(15) In this trial, patients with BP-I or II were randomly assigned to treatment with bupropion, paroxetine, or placebo added to an…”
ResultSelf-citationAmsterdam, J. D., Luo, L., & Justine Shults, A. (2013) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31828ea89e · Cited by 15
“40), with a similar rate of treatment-emergent mood conversion episodes in both groups.(9) Similarly, a 1-year naturalistic study of 1191 bipolar patients (356 patients with rapid cycling) found a 34% recovery rate and a 61% mood conversion and relapse rate during antidepressant drug use.”
BackgroundResultGorwood, P. A. P. M., Richard‐Devantoy, S., Sentissi, O., Strat, Y. L., & Olié, J. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.04.071 · Cited by 16
Deckersbach, T., Peters, A. T., Sylvia, L. G., Gold, A. K., Magalhães, P. V. D. S., Henry, D. B., Frank, E., Otto, M. W., Berk, M., Dougherty, D. D., et al. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.03.064 · Cited by 14
“However, pharmacotherapy alone often fails to bring patients to full and sustained remission (Sachs et al., 2007).”
InfluentialSelf-citationPrescribing practices of Indian psychiatrists in the treatment of bipolar disorder
Reddy, Y. C. J., Jhanwar, V., Nagpal, R., Reddy, M., Shah, N., Ghorpade, S., & Kulkarni, S. (2019) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867419826718 · Cited by 14
Lessons from STEP-BD for the treatment of bipolar depression
Nierenberg, A. A. (2009) · Depression and Anxiety · doi:10.1002/da.20547 · Cited by 13
“The main embedded randomized double-blind clinical trial of antidepressants (either paroxetine or bupropion) added to ongoing treatment used recovery as the primary outcome.([17]) Three hundred and sixtysix patients were randomized to 16 weeks of treatment.”
MethodSelf-citationSmith, E. G., Henry, A. D., Zhang, J., Hooven, F. H., & Banks, S. M. (2009) · Community Mental Health Journal · doi:10.1007/s10597-009-9199-2 · Cited by 13
Treatment of depressed bipolar patients with alcohol use disorders: Plenty of room for improvement
Baca‐García, E., Sher, L., Pérez-Rodríguez, M. M., Burke, A. K., Sullivan, G. M., Grunebaum, M. F., Stanley, B., Mann, J. J., & Oquendo, M. A. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.09.012 · Cited by 16
“Sachs et al. (2007) reported that the use of adjunctive antidepressant medication, as compared with the use of mood stabilizers, was not associated with increased efficacy.”
ResultLin, H., Erickson, S. R., & Balkrishnan, R. (2011) · Health Outcomes Research in Medicine · doi:10.1016/j.ehrm.2011.06.003 · Cited by 14
Adjunctive antidepressants in bipolar depression
Vieta, E., & Garriga, M. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30347-9 · Cited by 12
Systematic Review of Recent Guidelines for Pharmacological Treatments of Bipolar Disorders in Adults
Hammett, S., & Youssef, N. A. (2017) · Annals of Clinical Psychiatry · doi:10.1177/104012371702900409 · Cited by 14
“140 RANZ also suggests adding antidepressants, although it states that their use is controversial and evidence is inconsistent.”
Degree of exposure to psychotropic medications and mortality in people with bipolar disorder
Lin, C., Yeh, L., & Pan, Y. (2022) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13509 · Cited by 12
The king is dead, long live the king! The restoration of BALANCE
Malhi, G. S. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00851.x · Cited by 12
Pharmacological treatment of bipolar depression
Vázquez, G. H., Tondo, L., Undurraga, J. P., Zaratiegui, R. M., Selle, V., & Baldessarini, R. J. (2014) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.113.011460 · Cited by 13
Park, Y., & Lee, B.-H. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s104188 · Cited by 12
“Patients with major depressive episodes (MDEs) of bipolar disorder (BD) types I or II (BD I or BD II, respectively) generally exhibit weak responses to antidepressant (AD) therapy.1,2 In addition, most recent findings indicate that this high rate of resistance to ADs is not limited to BD I or II.”
BackgroundInfluentialEstimation and Optimization of Composite Outcomes
Luckett, D. J., Laber, E. B., & Kosorok, M. R. (2017) · Journal of Machine Learning Research · doi:10.48550/arxiv.1711.10581 · Cited by 27
Lamotrigine augmentation for the treatment-resistant mood disorder
Kagawa, S., Nemoto, K., Suzuki, T., Nagai, G., Nakamura, A. M., Mihara, K., & Kondo, T. (2010) · Clinical Neuropsychopharmacology and Therapeutics · doi:10.5234/cnpt.1.35 · Cited by 12
“Although the remission-oriented strategy is requisite as soon as possible after introducing the treatments of depression [3], there is no worldwide consensus among psychiatrists with regard to systematic intervention for refractory depression.”
BackgroundBipolar Spectrum Disorder: Differential Diagnosis and Treatment
Muzina, D. J. (2007) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2007.06.001 · Cited by 13
Quante, A., Zeugmann, S., Regen, F., Engelhardt, A., & Anghelescu, I. (2010) · Psychiatry Investigation · doi:10.4306/pi.2010.7.3.155 · Cited by 13
The Pharmacoepidemiology of Psychiatric Medications
Wang, P. S., Brookhart, A. M., Ulbricht, C. M., & Schneeweiß, S. (2011) · Wiley eBooks · doi:10.1002/9780470976739.ch10 · Cited by 13
The Rise and Fall of Mood Stabilizers
Malhi, G. S., & Goodwin, G. M. (2007) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670701579132 · Cited by 12
Bipolar spectrum disorders in primary care: optimising diagnosis and treatment
Smıth, D. J., Thapar, A., & Simpson, S. A. (2010) · British Journal of General Practice · doi:10.3399/bjgp10x484165 · Cited by 13
Adjunctive use of modafinil in bipolar patients: just another stimulant or not?
Shelton, R. C., & Reddy, R. (2008) · Current Psychiatry Reports · doi:10.1007/s11920-008-0082-6 · Cited by 11
Manic symptoms in patients with depressive and/or anxiety disorders
Berg, B., Penninx, B. W. J. H., Zitman, F. G., & Nolen, W. A. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.02.130 · Cited by 13
“…treatments, such as antidepressants as monotherapy (i.e. not combined with mood stabilizers) which in patients with bipolar depression not onlymay be less effective (Sachs et al., 2007) but alsomay have an increased risk of a manic switch or cycle acceleration (Bowden, 2005; Licht et al., 2008).”
BackgroundDistinguishing Symptoms of ADHD from Other Psychiatric Disorders in the Adult Primary Care Setting
Montano, C. B., & Weisler, R. (2011) · Postgraduate medicine · doi:10.3810/pgm.2011.05.2287 · Cited by 7
Lim, C., Olson, J., Zaman, A., Phelps, J., & Ingram, K. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181dc24f8 · Cited by 11
“Moreover, a recent multicenter randomized trial found that antidepressants were not better than placebo in the treatment of acute BD.(48) For these reasons, current expert consensus guidelines for the treatment of BD recommend against antidepressant monotherapy.”
BackgroundInfluentialElectroconvulsive Therapy in the Treatment of Mood Disorders: One-Year Follow-up
Çakır, S., & Çağlar, N. (2016) · Nöro Psikiyatri Arşivi · doi:10.5152/npa.2016.14845 · Cited by 12
“INTRODUCTON The efficacy of pharmacotherapy in mood disorders is not satisfactory, and the desired remission rates are not currently achieved in either unipolar (UD) or bipolar disorders (BP) (1,2,3).”
BackgroundRopinirole Augmentation for Depression: A Randomized Controlled Trial Pilot Study
Gershon, A. A., Amiaz, R., David, H. S., & Grunhaus, L. J. (2018) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000984 · Cited by 11
Dell’Osso, B. M., Cremaschi, L., Arici, C., Altamura, A. C., Hooshmand, F., Do, D., Shah, S., Gershon, A., Holsinger, A., Park, D. Y., et al. (2019) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000282 · Cited by 11
“Indeed, the rate of antidepressants usage was high both in Milan and Stanford samples, showing that, despite the evidence from the literature (Sachs et al., 2007; Sidor and Macqueen, 2011; Viktorin et al., 2014), this therapeutic option is still one of the most used in clinical practice for the…”
BackgroundSelf-citationAltınbaş, K., Smith, D., & Oral, E. T. (2011) · PubMed · Cited by 12
Long-term effectiveness of quetiapine in bipolar disorder in a clinical setting
Ketter, T. A., Brooks, J. O., Hoblyn, J. C., Holland, A. A., Nam, J. Y., Culver, J. L., Marsh, W., & Bonner, J. C. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.02.005 · Cited by 13
“Effectiveness studies attempt to bridge this gap, by involving more heterogeneous clinical samples, more complex treatment regimens, and more clinically relevant outcome measures such as recovery (Nierenberg et al., 2006; Sachs et al., 2007) or all-cause discontinuation (Lieberman et al.”
BackgroundSelf-citationIs There a Role for Antidepressants in the Treatment of Bipolar II Depression?
Suppes, T. M. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10040590 · Cited by 11
Bipolar Antidepressant Agents: Shaken not stirred
Malhi, G. S. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412445131 · Cited by 12
“, 2011), and the fact that STEP–BD (Sachs et al., 2007) showed a negative treatment effect that favoured placebo make it difficult to be conclusive.”
BackgroundComprehension and companionship in the emergency department as predictors of treatment adherence
Nitzan, U., Klein, E. H., Walter, G., Lurie, I., Aviram, S., & Bloch, Y. (2012) · Australasian Psychiatry · doi:10.1177/1039856211432485 · Cited by 10
Pharmaceutical treatment of acute bipolar depression
Fountoulakis, K. Ν. (2010) · F1000 Medicine Reports · doi:10.3410/m2-47 · Cited by 12
“3% in the placebo group) and switch rates to mania were similar [39].”
ResultKoola, M. M., FAWCETT, J. A., & Kelly, D. L. (2011) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e3182392d8f · Cited by 10
“Other pharmacological options were discussed, including adding a selective serotonin reuptake inhibitor (SSRI)/bupropion (Alda and Yatham, 2009; Sachs et al., 2007; Salvi et al., 2008), switching from lithium to lamotrigine, and adding lamotrigine or pramipexole.”
BackgroundLi, D., Tseng, P., Chen, Y., Wu, C.-K., & Lin, P. (2016) · Medicine · doi:10.1097/md.0000000000003165 · Cited by 14
Update on quetiapine in the treatment of bipolar disorder: results from the BOLDER studies
Gajwani, P., Muzina, D. J., Kemp, D. E., Gao, K., & Calabrese, J. R. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s1636 · Cited by 10
“In a recently published study (Sachs et al 2007), effectiveness of antidepressants with mood stabilizers was compared with placebo with mood stabilizers.”
Treating bipolar depression – antidepressants and alternatives: a critical review of the literature
Tundo, A., Cavalieri, P., Navari, S., & Marchetti, F. (2011) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2011.00542.x · Cited by 12
“’s (39) double-blind, placebo-controlled study, short-term AD treatment was associated with a switch risk that did not significantly differ from placebo (3.”
BackgroundResultThe Use of Antidepressants in Bipolar Depression
Beyer, J. L. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_155 · Cited by 13
Murata, S., Castillo, M. F. R., Murphy, M. L. M., Schwarz, M., Moll, N., Martin, B., Weidinger, E., Leitner, B., Mueller, N., & Halaris, A. E. (2019) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2019.07.001 · Cited by 10
Case 24-2008: A 35-Year-Old Woman with Postpartum Confusion, Agitation, and Delusions
Viguera, A. C., Emmerich, A. D., & Cohen, L. S. (2008) · New England Journal of Medicine · doi:10.1056/nejmcpc0804290 · Cited by 11
Bipolar (Manic Depressive) Disorders
El‐Mallakh, R. S., & Bauer, M. S. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch49 · Cited by 10
Approaching the Challenge of Bipolar Depression: Results From STEP-BD
Strakowski, S. M. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07060926 · Cited by 11
“These results mirror another recent publication from STEP-BD that found no advantage of adding antidepressants to mood stabilizers in the treatment of bipolar depression without concurrent manic symptoms (4).”
ResultAntidepressants in Bipolar Depression: An Enduring Controversy
Gitlin, M. J. (2019) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.17306 · Cited by 12
Altamura, A. C., & Dragogna, F. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413492572 · Cited by 9
“STEP-BD (Sachs et al., 2007), the first randomised discontinuation study with AD, not only showed that AD treatment produced no statistically significant symptomatic benefit in long-term management of BD, but that it also failed to prevent depressive episodes or improve remission rates (Ghaemi et al.”
BackgroundLlorca, P., Camus, V., Courtet, P., Gourion, D., Lukasiewicz, M., & Coulomb, S. (2013) · L Encéphale · doi:10.1016/j.encep.2013.04.010 · Cited by 10
Treatment of bipolar depression
Musetti, L., Grande, C. D., Marazziti, D., & Dell’Osso, L. (2013) · CNS Spectrums · doi:10.1017/s1092852912001009 · Cited by 10
“In contrast, the long-term use of adjunctive treatment with paroxetine or bupropion did not significantly increase the rate of recovery compared with mood stabilizers alone, although it did not enhance the risk of mood destabilization.(68) Overall, data on the risk of manic/hypomanic switch associated with the use of…”
BackgroundResultBipolar Depression: Molecular Neurobiology, Clinical Diagnosis, and Pharmacotherapy
Manji, H. K., & Zarate, C. A. (2016) · Milestones in drug therapy · doi:10.1007/978-3-319-31689-5 · Cited by 9
Bipolar-I Depression Outpatient Treatment Quality and Costs in Usual Care Practice
Busch, A. B., MD, Sachs, G. S., Frank, R. G., PhD, Sachs, A. G., & MD (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4317 · Cited by 9
Self-citationLi, K., Wei, Q., Li, G., He, X., Liao, Y., & Gan, Z. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s109941 · Cited by 10
“Considering the controversial effect of antidepressant on BD patients, 30–32 it is hard to judge whether patients with BD benefit from the use of antidepressants.”
Rajaratnam, K., Xiang, Y., Tripathi, A., Chiu, H. F. K., Si, T., Chee, K., Avasthi, A., Grover, S., Chong, M., Kuga, H., et al. (2017) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000670 · Cited by 9
CANMAT and ISBD 2018 guidelines for the management of patients with bipolar disorder
Strakowski, S. M. (2018) · Bipolar Disorders · doi:10.1111/bdi.12650 · Cited by 9
New Approaches in the Treatment of Bipolar Depression
Saunders, K., & Goodwin, G. M. (2012) · Current topics in behavioral neurosciences · doi:10.1007/7854_2012_209 · Cited by 11
Leyton, F., & Alvaro Barrera, P. (2010) · Revista médica de Chile · doi:10.4067/s0034-98872010000600017 · Cited by 14
Promising avenues of therapeutics for bipolar illness
Post, R. M. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.2/rmpost · Cited by 9
Antidepressants in the Treatment of Bipolar Disorder: Decoding Contradictory Evidence and Opinion
Eppel, A. (2008) · Harvard Review of Psychiatry · doi:10.1080/10673220802160381 · Cited by 9
Wrestling With Antidepressant Use in Bipolar Disorder: The Ongoing Debate
Goldberg, J. F., Nierenberg, A. A., & Iosifescu, D. V. (2021) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.19ac13181 · Cited by 9
“J Clin Psychiatry 2021;82(1):19ac13181”
Self-citationChiorean, A., Jones, B. D. M., Murong, M., Gonzalez‐Torres, C., Kloiber, S. M., Ortiz, A., Rosenblat, J. D., Mulsant, B. H., & Husain, M. I. (2024) · Bipolar Disorders · doi:10.1111/bdi.13440 · Cited by 11
Bipolar Depression: An Evidence-Based Approach
Baldassano, C. F., Hosey, A., & Coello, J. A. (2011) · Current Psychiatry Reports · doi:10.1007/s11920-011-0238-7 · Cited by 9
Troubles psychotiques aigus liés au bupropion : revue de la littérature
Javelot, T., Javelot, H., Baratta, A., Weiner, L., Messaoudi, M., & Lemoine, P. (2010) · L Encéphale · doi:10.1016/j.encep.2010.01.005 · Cited by 8
Mixed states: still a modern psychopathological syndrome?
Tortorella, A. A. V., Albert, U., Erfurth, A., Colom, F., Maina, G., Levi‐Montalcini, R., & Luigi-Gonzaga, S. (2015) · ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) · Cited by 11
Antidepressants have complex associations with longitudinal depressive burden in bipolar disorder
Hooshmand, F., Do, D., Shah, S., Gershon, A., Park, D. Y., Yuen, L. D., Dell’Osso, B. M., Wang, P. W., Miller, S., & Ketter, T. A. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.12.074 · Cited by 9
Self-citationKöhler‐Forsberg, O., Sylvia, L. G., Fung, V., Overhage, L., Thase, M. E., Calabrese, J. R., Deckersbach, T., Tohen, M. F., Bowden, C. L., McInnis, M. G., et al. (2020) · Depression and Anxiety · doi:10.1002/da.23069 · Cited by 10
“…Systematic Treatment Enhancement Program for Bipolar Disorder trial investigated antidepressant use adjunctive to mood‐stabilizing treatment in a randomized (Sachs et al., 2007) and a nonrandomized fashion (Goldberg et al., 2007), finding no differences between antidepressant users and nonusers.”
MethodSelf-citationTratamiento psicofarmacológico del trastorno bipolar en América Latina
Heeren, O., de Carmona, M. S., Vásquez, G., Córdoba, R., Forero, J., Madrid, L., Lara, D. R., Medina, R., & Meza, L. (2011) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2011.08.001 · Cited by 9
Frye, M. A., Hellemann, G. S., McElroy, S. L., Altshuler, L. L., Black, D. O., Keck, P. E., Nolen, W. A., Kupka, R., Leverich, G. S., Grunze, H., et al. (2011) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.9.4.foc540 · Cited by 8
Citrome, L. (2020) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001227 · Cited by 9
Modafinil Add-On in the Treatment of Bipolar Depression
Belmaker, R. H. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07050749 · Cited by 8
Adjunctive Antidepressant Treatment for Bipolar Depression
Henry, C., Demotes‐Mainard, J., & Leboyer, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmc071459 · Cited by 8
Schaffer, A., McIntosh, D., Goldstein, B. I., Rector, N. A., McIntyre, R. S., Beaulieu, S., Swinson, R., & Yatham, L. N. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400103 · Cited by 7
“Although several of these antidepressant trials have a sample size sufficient to address the issue, we did not find any reports on the impact of anxiety symptoms in antidepressant RCTs for bipolar depression, 55-57 other than those in which paroxetine was studied as an active comparator (level 2).”
Exposure to Antidepressant Medications and Suicide Attempts in Adult Depressed Inpatients
Olmer, A., Iancu, I., & Strous, R. D. (2012) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e318257c7e7 · Cited by 7
“Furthermore, some have noted that antidepressant treatment in bipolar depressed patients is not beneficial for recovery from depression (Sachs et al., 2007) and antidepressant monotherapy may predispose to a switch to mixed or manic episodes.”
BackgroundBipolar and Substance Use Disorder Comorbidity: Diagnostic and Treatment Considerations
Ostacher, M. J. (2011) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.9.4.foc428 · Cited by 9
Self-citationAmsterdam, J. D., & Xu, C. (2023) · Bipolar Disorders · doi:10.1111/bdi.13378 · Cited by 7
“11 15 Thus, the majority of current practice guidelines for treating bi-polar II depression have followed the treatment recommendations for those of bipolar I depression, by recommending lithium mono-therapy as first-line treatment, and only recommending the judicious use of antidepressant therapy…”
BackgroundConvulsive therapy for psychiatric disorders
Kaster, T. S., & Blumberger, D. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18496-3.00010-0 · Cited by 7
Hooshmand, F., Do, D., Shah, S., Gershon, A., Park, D. Y., Kim, H., Yuen, L. D., Dell’Osso, B. M., Wang, P. W., Ketter, T. A., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.02.091 · Cited by 9
Self-citationPhelps, J. R. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003315.003 · Cited by 7
Perinatal Depression Treatment Guidelines for Obstetric Providers
Higgins, N. E., Rose, M. J., Gardner, T. J., & Crawford, J. N. (2023) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2023.03.009 · Cited by 7
Köhler, S., Bauer, M., & Bschor, T. (2013) · Der Nervenarzt · doi:10.1007/s00115-013-3919-0 · Cited by 8
Overcoming the current approach in bipolar disorder research: towards DSM-V and beyond
Vieta, E. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108089592 · Cited by 7
Antidepressants: The scapegoat of poor outcome bipolar disorder?
Goldberg, J. F. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412441103 · Cited by 8
“(h) While a small literature espouses a higher risk for antidepressant-induced mania with TCAs or mixed agonists (such as the serotonin/ norepinephrine reuptake inhibitor venlafaxine; Post et al. (2006)) than SSRIs or bupropion, existing studies do not account for the aforementioned predisposing risk factors for patie…”
BackgroundInfluential
Metadata
- Authors
- Sachs, G. S., Nierenberg, A. A., Calabrese, J. R., Marangell, L. B., Wisniewski, S. R., Gyulai, L., Friedman, E. S., Bowden, C. L., Fossey, M. D., Ostacher, M. J., Ketter, T. A., Patel, J., Hauser, P., Rapport, D., Martinez, J. M., Allen, M. H., Miklowitz, D. J., Otto, M. W., Dennehy, E. B., & Thase, M. E.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- University Hospitals Cleveland Medical Center (US)
- Baylor College of Medicine (US)
- University of Pittsburgh (US)
- University of Pennsylvania (US)
- The University of Texas at San Antonio Health Science Center (US)
- University of Oklahoma (US)
- Stanford Medicine (US)
- University of Massachusetts Chan Medical School (US)
- University of Toledo (US)
- University of Colorado Boulder (US)
- Boston University (US)
- Purdue University West Lafayette (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-04-26
- Volume
- 356
- Issue
- 17
- Pages
- 1711-1722
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2166423384
- Semantic Scholar
- c224a40d0ffd6471e7b72b38060d169ba1cdec34
- Cited by
- 937
- References
- 27
- Citations by year
- 2026: 16 · 2025: 16 · 2024: 33 · 2023: 17 · 2022: 15 · 2021: 68 · 2020: 33 · 2019: 29 · 2018: 36 · 2017: 28 · 2016: 53 · 2015: 47 · 2014: 51 · 2013: 52 · 2012: 61
- FWCI
- 56.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01mh80001-12-0-0)
- National Institute of Mental Health (N01-MH80001)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Keywords
- bipolar depression, adjunctive antidepressant therapy, mood stabilizers, euthymia, bipolar disorder, antidepressant safety
- MeSH terms
- Adult, Bipolar Disorder, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Male, Bupropion, Treatment Outcome, Paroxetine, Antidepressive Agents, Second-Generation, Antimanic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.